Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia

J. C. Byrd, J. R. Brown, S. O'Brien, J. C. Barrientos, N. E. Kay, N. M. Reddy, S. Coutre, C. S. Tam, S. P. Mulligan, U. Jaeger, S. Devereux, P. M. Barr, R. R. Furman, T. J. Kipps, F. Cymbalista, C. Pocock, P. Thornton, F. Caligaris-Cappio, T. Robak, J. DelgadoS. J. Schuster, M. Montillo, A. Schuh, S. De Vos, D. Gill, A. Bloor, C. Dearden, C. Moreno, J. J. Jones, A. D. Chu, M. Fardis, J. McGreivy, F. Clow, D. F. James, P. Hillmen

Research output: Contribution to journal › Article › peer-review

1043 Scopus citations

Fingerprint

Dive into the research topics of 'Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences